Small-molecule drug discovery and development is limited by the ability of chemists to readily synthesize and purify new compounds with suitable chemical diversity. Now, a new twist on solid-phase chemical synthesis has enabled rapid and simplified synthesis of pharmaceutically relevant small molecules.
This is a preview of subscription content, log in via an institution to check access.
References
Berdigaliyev, N. & Aljofan, M. Future Med. Chem. 12, 939–947 (2020).
Amblard, M., Fehrentz, J.-A., Martinez, J. & Subra, G. Mol. Biotechnol. 33, 239–254 (2006).
Roy, B., Depaix, A., Périgaud, C. & Peyrottes, S. Chem. Rev. 116, 7854–7897 (2016).
Nicolaou, K. C. et al. Nature 387, 268–272 (1997).
Liu, C. et al. Nat. Chem. https://doi.org/10.1038/s41557-021-00662-w (2021).
Lee, J.-M. et al. Lancet Oncol. 19, 207–215 (2018).
Nandy, J. P. et al. Chem. Rev. 109, 1999–2060 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Kerr, M.S., Cole, K.P. Solid potential. Nat. Chem. 13, 399–401 (2021). https://doi.org/10.1038/s41557-021-00674-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41557-021-00674-6
- Springer Nature Limited